Volante Technologies introduces Multi-cloud Resiliency Service to ensure non-stop payments processing during major cloud outages
21.1.2026 15:00:00 CET | Business Wire | Press Release
Volante Technologies, the global leader in Payments as a Service (PaaS), today announced the launch of its premium Multi-cloud Resiliency Service, engineered to keep financial institutions’ payment operations running seamlessly during major cloud provider outages. Built on Volante’s proven cloud-native payments platform, the service provides true cross-cloud continuity, eliminating single-cloud/provider dependency for the payments layer.
Recent large-scale outages across hyperscale cloud providers have demonstrated the real-world impact of cloud concentration risk for banks: delayed or failed transactions, SLA penalties, customer churn, operational recovery costs, and reputational damage. While industry research estimates financial sector outages can exceed $2 million per hour, the financial exposure for many large and mid-sized financial institutions far exceeds this average, underscoring why resilience is now a business requirement, not a “nice to have.”
“Payments are the lifeblood of the global economy, and downtime is not an option,” said Vijay Oddiraju, CEO at Volante Technologies. “Operational resilience must be engineered and continuously proven, not treated as a document on a shelf. Our Multi-cloud Resiliency Service keeps payments running through major cloud disruptions, giving financial institutions confidence and their customers peace of mind in their banking experience.”
Volante’s Multi-cloud Resiliency Service directly addresses this challenge with rapid cross-cloud disaster recovery (DR) failover to a secondary cloud environment with a brief switchover window and zero data loss. PaaS clients can opt in at any time with minimal configuration changes, while Volante manages the ongoing operational readiness and testing behind the scenes, helping financial institutions align with regulatory expectations such as DORA and other global operational resilience frameworks.
“Cloud concentration risk isn’t theoretical—it’s a direct revenue, reputational, and regulatory issue for financial institutions, and single-provider architectures simply cannot meet resilience expectations as payments become increasingly cloud-native,” said Deepak Gupta, Chief Product, Engineering, and Delivery Officer, Volante Technologies. “Our Multi-cloud Resiliency Service is purpose-built for payments, enabling cross-cloud processing continuity when a primary cloud environment is unavailable, while helping our clients stay ahead of global regulatory demands.”
Built on Volante’s existing SaaS service, the Multi-cloud Resiliency Service extends an already secure and highly available foundation with additional layers of continuity and protection. The service includes data access restrictions, role-based entitlements, and encryption for data at rest and in transit. The solution maintains enterprise assurance through a comprehensive set of recognized certifications, including PCI DSS 4.0, SOC 1 Type 2 and SOC 2 Type 2, ISO 27001, ISO 27017, ISO 27018, ISO 22301, and ISO 27701.
Volante plans to continue expanding the Multi-cloud Resiliency Service with expanded cross-cloud capabilities, additional automation, and predictive analytics to support more proactive resilience planning and execution.
To learn more and schedule a demo, visit https://www.volantetech.com/platform-security/.
About Volante Technologies
Volante Technologies is the trusted cloud payments modernization partner to financial businesses worldwide, giving them the freedom to evolve and innovate at record speed. Real-time native, API enabled, and ISO 20022 fluent, Volante's Payments as a Service and underlying low-code platform process millions of mission-critical transactions and trillions in value daily. Volante’s customers include four of the top five global corporate banks, seven of the top ten U.S. banks, and two of the world’s largest card networks. Learn more at www.volantetech.com and linkedin.com/company/volante-technologies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260121732790/en/
Contacts
On behalf of Volante Technologies:
Americas
Julian Byrne
anthonyBarnum Public Relations
Tel. +1 (512) 665-9258
julian.byrne@anthonybarnum.com
EMEA
Assyria Graves
Hard Numbers
Tel: +44 75 0787 0214
pr@volantetech.com
assyria@hardnumbers.co.uk
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom